DK1117409T3 - Benzensulfonyl(thio)ureaforbindelser i kombination med beta-blokkere til behandling af dysfunktioner i det autonome nervesystem - Google Patents

Benzensulfonyl(thio)ureaforbindelser i kombination med beta-blokkere til behandling af dysfunktioner i det autonome nervesystem

Info

Publication number
DK1117409T3
DK1117409T3 DK99944585T DK99944585T DK1117409T3 DK 1117409 T3 DK1117409 T3 DK 1117409T3 DK 99944585 T DK99944585 T DK 99944585T DK 99944585 T DK99944585 T DK 99944585T DK 1117409 T3 DK1117409 T3 DK 1117409T3
Authority
DK
Denmark
Prior art keywords
benzenesulfonyl
blockers
thio
beta
treatment
Prior art date
Application number
DK99944585T
Other languages
English (en)
Inventor
Klaus Wirth
Heinrich Christian Englert
Helmut Bohn
Heinz Goegelein
Holger Heitsch
Uwe Gerlach
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998141534 external-priority patent/DE19841534A1/de
Priority claimed from DE1999101061 external-priority patent/DE19901061A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1117409T3 publication Critical patent/DK1117409T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42Sulfonylthioureas; Sulfonylisothioureas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52Y being a hetero atom
    • C07C311/54Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/54Silicon-containing compounds
    • C08K5/5406Silicon-containing compounds containing elements other than oxygen or nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99944585T 1998-09-10 1999-09-02 Benzensulfonyl(thio)ureaforbindelser i kombination med beta-blokkere til behandling af dysfunktioner i det autonome nervesystem DK1117409T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998141534 DE19841534A1 (de) 1998-09-10 1998-09-10 Verwendung von Benzolsulfonyl(thio)harnstoffen zur Behandlung und Prophylaxe von Dysfunktionen des autonomen Nervensystems und Verwendung von Benzolsulfonyl(thio)harnstoffen in Kombination mit Betarezeptoren-Blockern
DE1999101061 DE19901061A1 (de) 1999-01-14 1999-01-14 Verwendung von Benzolsulfonyl(thio)harnstoffen zur Behandlung von Prophylaxe von Dysfunktionen des autonomen Nervensystems und Verwendung von Benzolsulfonyl(thio)harnstoffen in Kombination mit Betarezeptoren-Blockern
PCT/EP1999/006450 WO2000015204A2 (en) 1998-09-10 1999-09-02 Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers

Publications (1)

Publication Number Publication Date
DK1117409T3 true DK1117409T3 (da) 2005-05-30

Family

ID=26048790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99944585T DK1117409T3 (da) 1998-09-10 1999-09-02 Benzensulfonyl(thio)ureaforbindelser i kombination med beta-blokkere til behandling af dysfunktioner i det autonome nervesystem

Country Status (27)

Country Link
US (1) US6414030B1 (da)
EP (1) EP1117409B1 (da)
JP (1) JP4733268B2 (da)
KR (1) KR100981592B1 (da)
CN (1) CN1195524C (da)
AR (1) AR020411A1 (da)
AT (1) ATE287718T1 (da)
AU (1) AU762832B2 (da)
BR (1) BR9913572A (da)
CA (1) CA2343009C (da)
CZ (1) CZ301165B6 (da)
DE (1) DE69923464T2 (da)
DK (1) DK1117409T3 (da)
ES (1) ES2235507T3 (da)
HK (1) HK1040187B (da)
HU (1) HU228988B1 (da)
ID (1) ID28854A (da)
IL (2) IL141414A0 (da)
MY (1) MY121798A (da)
NO (1) NO330215B1 (da)
NZ (1) NZ510424A (da)
PL (1) PL194986B1 (da)
PT (1) PT1117409E (da)
RU (1) RU2247562C2 (da)
TR (1) TR200100692T2 (da)
TW (1) TWI238817B (da)
WO (1) WO2000015204A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19917233A1 (de) * 1999-04-16 2000-10-19 Aventis Pharma Gmbh Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids
DE19923086A1 (de) 1999-05-20 2000-11-23 Aventis Pharma Gmbh Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US7620611B1 (en) * 1999-07-20 2009-11-17 Trilithic, Inc. Neural networks for ingress monitoring
DE10054482A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10129704A1 (de) * 2001-06-22 2003-01-02 Aventis Pharma Gmbh Verwendung von Benzolsulfonyl(thio)harnstoffen in der Behandlung des septischen Schocks
CN1330630C (zh) * 2004-03-10 2007-08-08 中国药科大学 新的磺酰(硫)脲衍生物、其制备方法及含有它们的药物组合物
DE102004061017A1 (de) * 2004-12-18 2006-06-22 Sanofi-Aventis Deutschland Gmbh Piperidinsulfonylharnstoffe und -thioharnstoffe, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
ES2485492T3 (es) * 2007-06-05 2014-08-13 Sanofi Derivados de di(hetero)arilciclohexano, su preparación, su uso y composiciones farmacéuticas que los comprenden

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1185180B (de) * 1963-10-19 1965-01-14 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1518874C3 (de) * 1964-10-07 1975-03-13 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE3009047A1 (de) 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Neue l-(acylamino-aryloxy-)2-hydroxy-3-alkinylaminopropane und verfahren zu ihrer herstellung
GB8716972D0 (en) * 1987-07-17 1987-08-26 Pfizer Ltd Treatment of cardiac arrhythmias
DK0612724T3 (da) 1993-02-23 1997-06-16 Hoechst Ag Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og deres anvendelse som farmaceutika
DE19505397A1 (de) * 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
HUP9900377A3 (en) 1995-03-10 2000-03-28 Hoechst Marion Roussel Inc Cin Novel process for preparing 2,3-dihydro-benzofuranol derivatives
FR2746013B1 (fr) 1996-03-18 1998-05-29 Sanofi Sa Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus

Also Published As

Publication number Publication date
IL141414A (en) 2006-07-05
NZ510424A (en) 2003-06-30
HUP0103534A2 (hu) 2002-05-29
BR9913572A (pt) 2001-05-22
NO20011117D0 (no) 2001-03-05
EP1117409A2 (en) 2001-07-25
CZ2001858A3 (en) 2001-06-13
IL141414A0 (en) 2002-03-10
NO330215B1 (no) 2011-03-07
HU228988B1 (hu) 2013-07-29
ID28854A (id) 2001-07-05
HUP0103534A3 (en) 2003-09-29
HK1040187B (zh) 2005-09-02
WO2000015204A2 (en) 2000-03-23
CA2343009A1 (en) 2000-03-23
TWI238817B (en) 2005-09-01
PL347215A1 (en) 2002-03-25
US20020082300A1 (en) 2002-06-27
PL194986B1 (pl) 2007-07-31
NO20011117L (no) 2001-05-02
AU762832B2 (en) 2003-07-03
TR200100692T2 (tr) 2001-07-23
AR020411A1 (es) 2002-05-08
CN1319014A (zh) 2001-10-24
CZ301165B6 (cs) 2009-11-25
WO2000015204A3 (en) 2000-07-13
JP2002524497A (ja) 2002-08-06
CN1195524C (zh) 2005-04-06
ES2235507T3 (es) 2005-07-01
DE69923464D1 (de) 2005-03-03
AU5744499A (en) 2000-04-03
EP1117409B1 (en) 2005-01-26
JP4733268B2 (ja) 2011-07-27
KR100981592B1 (ko) 2010-09-13
HK1040187A1 (en) 2002-05-31
PT1117409E (pt) 2005-04-29
ATE287718T1 (de) 2005-02-15
CA2343009C (en) 2011-03-15
DE69923464T2 (de) 2006-05-11
RU2247562C2 (ru) 2005-03-10
US6414030B1 (en) 2002-07-02
KR20010086396A (ko) 2001-09-10
MY121798A (en) 2006-02-28

Similar Documents

Publication Publication Date Title
ZA991578B (en) Compounds for the treatment of ischemia.
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
ZA200202461B (en) Compounds for the treatment of ischemia.
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
ID23989A (id) Turunan-turunan amida atau garam-garamnya
NO992524D0 (no) Konsenserte bicykliske pyrimidin-derivater
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
EP1027054A4 (en) LOCAL CONTRIBUTION OF PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION
HUP0201708A3 (en) The use of nucleoside analogues for treating leukemia
HUP0100705A3 (en) Combination effective for the treatment of impotence
DK1117409T3 (da) Benzensulfonyl(thio)ureaforbindelser i kombination med beta-blokkere til behandling af dysfunktioner i det autonome nervesystem
NO990805D0 (no) Remedium for ereksjonssvikt omfattende kondenserte pyridazinforbindelser
GB2359810B (en) Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
EE200000391A (et) Triasiiniühendid kesknärvisüsteemihäirete raviks
DK0935598T3 (da) 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet
NO983311L (no) FremgangsmÕte for Õ forhindre sulfidst÷veksplosjoner i forbindelse med etterblÕsing
DK1121356T3 (da) 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser
NO20012616L (no) Middel til behandling av erektil malfunksjon
NO20012538D0 (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
DK0964681T3 (da) Antikonvulsive derivater til behandling af psoriasis
GB2351440B (en) Bath, basin or sink with overflow prevention arrangement
SI1117409T1 (en) Benzenesulfonyl(thio)ureas in combination with beta-blockers for the treatment of dysfunctions of the autonomous nervous system
KR970055848U (ko) 장구부전의 잠금장치
KR970052505U (ko) 전로출강시의 슬래그차단용 체크볼